Table 1 Baseline Parameters in patients prior to terlipressin initiation
From: Use of terlipressin in critically ill children with liver disease
Parameter | Median (IQR) |
|---|---|
Age (in years) | 10 (6.1–14.4) |
Weight (in kg) | 26 (17.5–45) |
Sex (male children) | 52.38% |
Bleeding varices | 16/21 |
Ascites | 14/21 |
Concomitant noradrenaline usage | 14/21(mean dose: 0.25 μg/kg/min) |
10 (0.27–25) | |
0.399 (0.089–0.87) | |
LIU score [19] | 160 (115–141) |
4.4 (3.6–12.4) | |
PELOD score [22] | 21 (12–31) |
Hepatorenal syndrome-acute kidney injury | 7/21 |
Baseline MAP (mmHg) | 60 (52–68) |
Baseline Urine output (ml/kg/hr) | 0.055 (0–0.57) |
Baseline Creatinine (μmol/L) | 67 (36.5–97) |
Baseline sodium (mmol/L) | 138 (135–140) |
Baseline lactate | 2.24 (1.29–4.5) |